Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
On April 15, 2013, the Supreme Court heard oral argument in <i>Ass'n for Molecular Pathology v. U.S. Patent and Trademark Office</i> (hereinafter "<i>Myriad</i>"). The sole question before the Supreme Court, following its grant of certiorari on Nov. 30, 2012, is whether human genes are patent-eligible subject matter under 35 U.S.C. ' 101.
Columns & Departments
Highlights of the latest equipment leasing news from around the country.
Features
A lender's right to recover a make-whole premium as part of its allowed claim in a bankruptcy case has been the subject of considerable judicial debate over the past number of years, with some courts allowing recovery and others denying it. Earlier this year, the U.S. Bankruptcy Court for the Southern District of New York added to the debate by denying bondholders the right to payment of a make-whole premium in connection with the debtor's refinancing of the bond debt.
Columns & Departments
Highlights of the latest franchising cases from around the country.
Features
Proposed franchise legislation featured prominently in "An Agenda for Justice," a report recently released by the British Columbia Branch of the Canadian Bar Association.
This article discusses the important lessons that buyers, sellers and their professional advisers seem to have drawn in the last few years with respect to private equity's involvement in franchising.
Columns & Departments
Analysis and discussion of several major rulings.
Columns & Departments
Two recent rulings and what they mean.
Columns & Departments
In-depth analysis of a key ruling.
Columns & Departments
A look at <i>Pomerance v. McGrath</i> and what it means.
